Monoclonal antibodies to the map protein and method of use in treating or preventing infections
CA 2425000 A1 · Owner: Patti, Joseph M. · Inventors: Patel, Pratiksha; Patti, Joseph M.; Domanski, Paul
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Monoclonal and polyclonal antibodies to the binding subdomains of the MAP protein, including the Map 10 protein, or other immunogenic subregions of the MAP protein, are provided which can be useful in the treatment of and protection against infection from staphylococcal bacteria such as Staphylococcus aureus. In addition, medical instruments can be treated using the antibodies of the invention in order to reduce or eliminate the possibility of their becoming infected or further spreading the infection. In particular, the antibodies of the present invention are advantageous because they serve the double purpose of preventing adherence of the bacteria to host cells and enhancing the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 22, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 22, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 22, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.